期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 55, 期 20, 页码 8879-8890出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm301160h
关键词
-
资金
- Wellcome Trust [087792]
- Medical Research Council [0900278, U117532067]
- EU F97 project MALSIG [HEALTH-F3-2009-223044]
- Biotechnology and Biological Sciences Research Council [BB/D02014X/1] Funding Source: researchfish
- Medical Research Council [MC_U117532067, G0900278] Funding Source: researchfish
- BBSRC [BB/D02014X/1] Funding Source: UKRI
- MRC [MC_U117532067, G0900278] Funding Source: UKRI
Design of inhibitors for N-myristoyltransferase (NMT), an enzyme responsible for protein trafficking in Plasmodium falciparum, the most lethal species of parasites that cause malaria, is described. Chemistry-driven optimization of compound 1 from a focused NMT inhibitor library led to the identification of two early lead compounds 4 and 25, which showed good enzyme and cellular potency and excellent selectivity over human NMT. These molecules provide a valuable starting point for further development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据